Loading clinical trials...
Loading clinical trials...
A Proof of Concept Study to Evaluate the Peak Bronchoprotection Conferred by Single and Chronic Dosing With Levosalbutamol and Racemic Salbutamol in Persistent Asthmatics.
Conditions
Interventions
levosalbutamol
racemic salbutamol
+1 more
Locations
1
United Kingdom
Asthma and Allergy Research Group
Dundee, Angus, United Kingdom
Start Date
January 1, 2009
Primary Completion Date
January 1, 2010
Completion Date
January 1, 2010
Last Updated
June 12, 2012
NCT07486401
NCT02327897
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
University of Dundee
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions